RAC2 and myeloid sarcoma: MR analyses involving SNPs in these gene regions found only a link between the expression levels of RAC2 and MS, suggesting that statins may reduce MS risk using a cholesterol-independent pathway, specifically through a RAC2-related mechanism(s).